Clin Pharmacol Adv Appl 8:177189 Atashrazm F, Hammond D, Perera G, Dobson-Stone C, Mueller N, Pickford R, Kim WS, Kwok JB, Lewis SJG, Halliday GM, Dzamko N (2018) Reduced glucocerebrosidase activity in monocytes from patients with Parkinsons disease
Han et al., 2013)
10.1016/S2213-8587(19)30249-9 57 KunaR
En situation de stress oxydatif exposition toxique, inflammation, effort intense ce ratio chute, traduisant un puisement des capacits antioxydantes de la cellule et une accumulation d'ERO qui endommagent les structures cellulaires
Lee E, Padgett B
Separations 9(11):331 Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I, Patrizio A, Gonnella D, Giusti C, Virili C (2020) Graves disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy